Thursday, 13 August 2020

Piramal Pharma Solutions receives recognition from Frost & Sullivan

23 July 2019 | News

For its End-to-End Integrated Services Across the Entire Drug Development Life Cycle

Based on its recent analysis of the contract development and manufacturing organization market, Frost & Sullivan recognized Piramal Pharma Solutions ('PPS', 'the business') with the 2019 Global Customer Service Leadership Award. Through its 12 development centers and manufacturing sites across North America, Europe, and Asia, PPS provides end-to-end capabilities to its pharmaceutical customers across the entire drug development life cycle. It combines its global operational capabilities and standardized scheduling to minimize supply chain constraints and shorten delivery timelines for customers. The business also deploys an innovative quality framework across its global manufacturing network.

"With unparalleled research and development (R&D) focus, PPS strives to re-engineer its internal capabilities, programs, and new technologies to expedite a drug's time-to-market," said Khushbu Jain, Industry Analyst at Frost & Sullivan. "PPS' offerings include drug discovery, drug development, and drug substance and product commercial manufacturing. By having half of its manufacturing sites in the East and the other half in the West, it ensures flexible scheduling for shorter delivery timelines and significant resource and time savings."

PPS' R&D team resolves complex process development and formulation challenges and develops robust processes for customers. The business has proven expertise in injectable capabilities and provides complete contract development and manufacturing capabilities across active pharmaceutical ingredients (API) and formulations, including niche capabilities in handling cytotoxic injectables, hormonal formulations, and high potency APIs (HPAPIs). 


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account